This Week in Nature

In Nature this week, research led by Novartis' Feng Cong identified a new molecule in the Wnt signaling pathway that could potentially be a target in Wnt-dependent cancers. Using a chemical genetic screen, the scientists found that XAV939, a small molecule that selectively inhibits beta-catenin-mediated transcription, effectively stabilizes axin.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.